PlayStation 5 Price Increase Leads to Surge in Micron and Sandisk Stock Prices.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 27 2026
0mins
Source: Barron's
- Price Increase Announcement: Sony is increasing the prices of its PlayStation consoles due to ongoing economic pressures.
- Cause of Price Hike: The rise in prices is attributed to soaring memory costs impacting the production of the consoles.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTC
Wall Street analysts forecast INTC stock price to fall
29 Analyst Rating
5 Buy
19 Hold
5 Sell
Hold
Current: 121.100
Low
20.00
Averages
39.30
High
52.00
Current: 121.100
Low
20.00
Averages
39.30
High
52.00
About INTC
Intel Corporation is a global designer and manufacturer of semiconductor products. The Company's segments include Intel Products, Intel Foundry, and All Other. Its Intel Products comprise Client Computing Group (CCG) and Data Center and AI (DCAI). CCG delivers platforms and processors that power PCs and edge devices, enabling enhanced performance, connectivity and user experience for consumer and commercial markets with capabilities that also support retail, industrial robotics and AI ecosystems at the edge. DCAI delivers workload-optimized solutions based upon its x86 architecture for data centers, including CPUs, AI accelerators, NICs, IPUs and custom ASICs, enabling performance and scalability for cloud, enterprise, telecommunication and HPC environments. The Intel Foundry segment comprises technology development, manufacturing and foundry services, developing new semiconductor process technologies and advanced packaging technologies. All Other segments include Mobileye and Other.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Arm's Growth Drivers: Arm is benefiting from AI, efficiency improvements, and licensing growth across multiple platforms, demonstrating strong competitiveness in the tech sector and is expected to further solidify its market position.
- Intel's Strategic Comeback: Intel seeks a strategic resurgence through data center expansion and foundry services; despite facing fierce competition, its new business model may provide fresh momentum for future growth.
- Market Price Dynamics: As of June 11, 2026, Arm and Intel's stock prices increased by 4.88% and 10.75% respectively, reflecting investor confidence in both companies' future developments and shifts in market expectations.
- Long-Term Prospects Comparison: The video analyzes key catalysts and market debates for both companies, indicating that Arm may possess stronger growth potential in the long run, particularly in AI applications.
See More
- AI and Efficiency Gains: Arm is benefiting from AI and efficiency improvements across multiple platforms, driving licensing growth and indicating the company's sustained leadership in technological innovation, which may lay the groundwork for future revenue increases.
- Intel's Strategic Comeback: Intel seeks a strategic comeback through data center expansion and foundry services; despite facing fierce competition, its transformation efforts could improve market share and profitability in the coming years.
- Investment Recommendations: Although Arm shows strong performance in AI, The Motley Fool's analyst team did not include it in the current best stock picks, reflecting a cautious market sentiment regarding its long-term potential, prompting investors to evaluate carefully.
- Historical Return Comparison: With a total average return of 936% compared to the S&P 500's 209%, Stock Advisor highlights the importance of selecting the right investment portfolio to achieve high returns, urging investors to stay attuned to market dynamics for optimal decision-making.
See More
- IPO Success and Valuation: SpaceX's IPO on June 12, 2026, raised $85.7 billion, valuing the company in the trillions and making Elon Musk the world's first trillionaire, significantly boosting investor confidence in its future prospects.
- Space Data Center Vision: SpaceX plans to establish a constellation of up to one million satellites in low Earth orbit to support its orbital AI data center concept, with expectations that costs will become lower than terrestrial data centers within two to three years, presenting a strong business case.
- Technical Collaboration and Investment: SpaceX is partnering with Tesla and Intel to create Terafab, a 10-million-square-foot facility set to open in 2029 with an investment of up to $119 billion, aimed at meeting the massive semiconductor demand and advancing space computing capabilities.
- Intensifying Market Competition: Companies like Amazon and Google are also actively pursuing space data centers, with Amazon's Project Sunrise set to launch in 2027 and Google's collaboration with Planet Labs exploring solar-powered satellite networks, indicating increasing competition in the space computing market.
See More
- Earnings Complexity: FedEx is set to report its fiscal 2026 Q4 earnings on Tuesday, covering the March-to-May period, with the complexity arising from the spin-off of FedEx Freight, which complicates direct financial comparisons and may impact market expectations for the company’s future.
- Profitability Expectations: Analysts forecast FedEx to report revenues of $24.04 billion and earnings per share of $5.96, although the combination of the fiscal year calendar change and the spin-off may lead to mixed market reactions, necessitating a focus on profitability metrics.
- Freight Business Outlook: FedEx Freight is expected to achieve modest revenue growth post-spin-off, despite facing pressure on adjusted operating margins due to spin-off-related costs such as technology investments, with the market keenly awaiting insights during Thursday's investor day.
- Inflation Data Impact: The personal consumption expenditures price index (PCE) will be released on Thursday, and while the May consumer price index (CPI) hit a three-year high of 4.2%, the recent drop in oil prices may alleviate future inflation pressures, influencing the Fed's rate hike outlook.
See More
- Sandisk New Business Model: Analyst Wamsi Mohan highlights Sandisk's shift to a new business model focused on multiyear contracts to mitigate revenue fluctuations, which is expected to enhance the company's pricing power and positively impact stock performance.
- Dynatrace High Growth Potential: Analyst Koji Ikeda raises Dynatrace's price target to $50 per share, believing its AI-driven software will drive strategic deals and strong growth in annual recurring revenue, despite a 4% decline in shares year-to-date.
- Meta AI Search Opportunity: Analyst Justin Post notes that Meta has significant market opportunities following the rollout of its new AI search feature, with expectations that AI will strengthen search indexing, even as shares have fallen 13% year-to-date.
- Nvidia Reasonable Valuation: Bank of America sets Nvidia's price target at $350 per share, based on its leading position in the fast-growing AI computing market, acknowledging some volatility in global AI projects but maintaining an optimistic long-term outlook.
See More
- Collaboration Background: Greenstone Biosciences and Intel Corp. have announced a partnership to leverage Greenstone's human induced pluripotent stem cell biobank and Intel's Edge AI computing infrastructure to accelerate AI-enabled drug discovery, aiming to enhance drug safety and advance precision medicine.
- Technology Integration: This collaboration combines Greenstone's advanced human genetics with Intel's purpose-built silicon, facilitating large-scale data processing, storage, and analysis, which is expected to significantly reduce development costs and expedite time-to-market for new drugs.
- Regulatory Support: The partnership aligns with the growing regulatory momentum from the US FDA towards New Approach Methodologies (NAMs), aiming to improve the translational relevance of preclinical testing through human cellular models and AI analytics, thereby fostering innovation in the biotech and pharmaceutical sectors.
- Industry Impact: The integration of Greenstone's iPSC platform with Intel's computing architecture enables the identification of patient-specific response patterns and improves the prediction of adverse drug effects, marking a significant step towards more human-centered drug development.
See More











